459 related articles for article (PubMed ID: 7400305)
1. Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. Dissociation of responses to dopamine and bromocriptine.
Carey RM; Thorner MO; Ortt EM
J Clin Invest; 1980 Jul; 66(1):10-8. PubMed ID: 7400305
[TBL] [Abstract][Full Text] [Related]
2. Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. Dopaminergic control of aldosterone.
Carey RM; Thorner MO; Ortt EM
J Clin Invest; 1979 Apr; 63(4):727-35. PubMed ID: 438333
[TBL] [Abstract][Full Text] [Related]
3. Dopaminergic regulation of 18-hydroxycorticosterone and aldosterone secretion in man.
Sowers JR; Beck FW
Acta Endocrinol (Copenh); 1983 Feb; 102(2):258-64. PubMed ID: 6338674
[TBL] [Abstract][Full Text] [Related]
4. Acute dopaminergic inhibition of aldosterone secretion is independent of angiotensin II and adrenocorticotropin.
Carey RM
J Clin Endocrinol Metab; 1982 Feb; 54(2):463-9. PubMed ID: 6274907
[TBL] [Abstract][Full Text] [Related]
5. Selectivity of metoclopramide for endocrine versus renal effects of dopamine in normal humans.
Blumberg AL; Dubb JW; Allison NL; Aldins Z; Ramey K; Stote RM
J Cardiovasc Pharmacol; 1988 Feb; 11(2):181-6. PubMed ID: 2452312
[TBL] [Abstract][Full Text] [Related]
6. Effect of atrial natriuretic hormone on metoclopramide-induced stimulation of aldosterone.
Shenker Y; Meranda D; Clinkingbeard C; Lawrence D; Koch D
J Lab Clin Med; 1992 Aug; 120(2):297-304. PubMed ID: 1323636
[TBL] [Abstract][Full Text] [Related]
7. Dopaminergic modulation of aldosterone secretion in the rhesus monkey: evidence that dopamine affects the late pathway of aldosterone biosynthesis by inhibiting the conversion of corticosterone to 18-hydroxycorticosterone.
Sowers JR; Berg G; Martin VS; Mayes DM
Endocrinology; 1982 Apr; 110(4):1173-7. PubMed ID: 7060520
[TBL] [Abstract][Full Text] [Related]
8. Influence of sodium homeostasis on dopaminergic modulation of aldosterone, renin, and prolactin secretion in man.
Sowers JR; Glub MS; Eggena PH; Catania RA
J Clin Endocrinol Metab; 1982 Jan; 54(1):121-6. PubMed ID: 7033264
[TBL] [Abstract][Full Text] [Related]
9. Dopaminergic effects on kidney function and responsiveness of aldosterone, plasma renin activity, prolactin, catecholamines, and blood pressure to stimulation in patients with prolactinoma. Comparison of the efficacy of pergolide and bromocriptine therapy.
Jungmann E; Haak T; Althoff PH; Fassbinder W; Schöffling K
Arzneimittelforschung; 1988 Feb; 38(2):296-300. PubMed ID: 3285838
[TBL] [Abstract][Full Text] [Related]
10. Effect of upright posture on the aldosterone responses to dopamine, metoclopramide, angiotensin II, and adrenocorticotropin.
Malchoff CD; Hughes JM; Carey RM
J Clin Endocrinol Metab; 1987 Jul; 65(1):203-7. PubMed ID: 3034955
[TBL] [Abstract][Full Text] [Related]
11. Plasma aldosterone response to metoclopramide in patients with Cushing's disease.
Zacharieva S; Stoeva I; Matrozov P; Andonova K
Exp Clin Endocrinol; 1993; 101(3):138-43. PubMed ID: 8223981
[TBL] [Abstract][Full Text] [Related]
12. Metoclopramide does not inhibit atrial natriuretic factor-stimulated diuresis in man.
Farrow S; Mahayni A; Banta G; Sowers J; Lockette W
Aviat Space Environ Med; 1996 Mar; 67(3):248-52. PubMed ID: 8775403
[TBL] [Abstract][Full Text] [Related]
13. Dopamine selectively inhibits aldosterone responses to angiotensin II in man.
Carey RM; Drake CR
J Hypertens Suppl; 1984 Dec; 2(3):S267-9. PubMed ID: 6100739
[TBL] [Abstract][Full Text] [Related]
14. Influence of sodium homeostasis and circadian rhythm on dopaminergic modulation of 18-hydroxycorticosterone secretion in man.
Sowers JR; Stern N
J Clin Endocrinol Metab; 1982 Dec; 55(6):1046-51. PubMed ID: 7130335
[TBL] [Abstract][Full Text] [Related]
15. Aldosterone response to metoclopramide in patients with prolactinoma: effect of short-term bromocriptine treatment.
Zacharieva S; Stoeva I; Andreeva M; Kalinov K; Matrozov P; Andonova K
Methods Find Exp Clin Pharmacol; 1996 Nov; 18(9):593-7. PubMed ID: 9010834
[TBL] [Abstract][Full Text] [Related]
16. Dopaminergic receptor mechanisms modulating the renin-angiotensin system and aldosterone secretion: an overview.
Missale C; Lombardi C; De Cotiis R; Memo M; Carruba MO; Spano PF
J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S29-39. PubMed ID: 2483440
[TBL] [Abstract][Full Text] [Related]
17. Altered dopaminergic modulation of prolactin and aldosterone secretion in pseudohypoparathyroidism.
Sowers JR; Brickman AS; Asp N; Tuck ML; Jasberg K; Magnone S
J Clin Endocrinol Metab; 1981 May; 52(5):914-8. PubMed ID: 7014587
[TBL] [Abstract][Full Text] [Related]
18. Effect of metoclopramide and domperidone on aldosterone, 18-hydroxycorticosterone and prolactin secretion in the rhesus monkey.
Sowers JR; Eggena P; Phillips D
Metabolism; 1982 Dec; 31(12):1219-23. PubMed ID: 7144566
[TBL] [Abstract][Full Text] [Related]
19. Bromocriptine does not inhibit the aldosterone response to sodium depletion.
Carey RM; Van Loon GR
J Clin Endocrinol Metab; 1982 Jul; 55(1):162-5. PubMed ID: 7042738
[TBL] [Abstract][Full Text] [Related]
20. Modulation of corticosteroid secretion by dopaminergic mechanisms in rhesus monkeys.
Sowers JR
Am J Physiol; 1982 Nov; 243(5):E375-9. PubMed ID: 7137342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
